In a 52-year-old woman who is 1.5 years after her final menstrual period, which hormonal change is expected according to the Stages of Reproductive Aging Workshop (STRAW) + 10 classification?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Increased FSH is the Expected Hormonal Change

At 1.5 years post-final menstrual period (FMP), this patient is in the early postmenopausal stage (Stage +1c according to STRAW+10), and the expected hormonal change is increased follicle-stimulating hormone (FSH).

Hormonal Changes in Early Postmenopause

FSH Elevation

  • FSH levels progressively increase across the menopausal transition and remain elevated in postmenopause 1, 2
  • Research demonstrates that FSH significantly increases from Stage -2 (early transition) through Stage +2 (late postmenopause), with the most dramatic rise occurring around the FMP 3
  • This elevation reflects the loss of negative feedback from declining ovarian follicles and is a hallmark of postmenopausal physiology 4

Why the Other Options Are Incorrect

Decreased LH: This is incorrect. LH actually increases (not decreases) in postmenopause, similar to FSH, though the rise is less pronounced. Both gonadotropins remain elevated due to loss of ovarian feedback 4.

Estradiol as predominant estrogen: This is incorrect. In postmenopause, estrone becomes the predominant estrogen, not estradiol. Estradiol levels decline dramatically—by approximately 67% in the 4-year period surrounding the FMP (from 2 years before to 2 years after) 5. By 1.5 years post-FMP, estradiol levels are markedly reduced, typically below 20 pg/mL 6.

Increased testosterone: This is incorrect. While testosterone levels may remain relatively stable or decline gradually with aging, there is no characteristic increase in testosterone during early postmenopause. The dominant hormonal change is the rise in gonadotropins (FSH and LH) in response to ovarian failure.

Clinical Context

The STRAW+10 classification uses menstrual patterns as the primary staging criterion, with hormonal measures serving as supportive criteria 2. At 1.5 years post-FMP, this patient is definitively postmenopausal, and the characteristic hormonal profile includes:

  • Elevated FSH (typically >25-40 IU/L)
  • Elevated LH
  • Low estradiol (<20 pg/mL)
  • Estrone as the predominant circulating estrogen

This hormonal pattern reflects complete loss of ovarian follicular activity and is consistent across different populations and ethnic groups 3, 1.

References

3
Research

Evaluating the menopausal transition with the STRAW + 10 in a Brazilian cohort of women with HIV, 2015-2016.

Climacteric : the journal of the International Menopause Society, 2021

4
Research

Reproductive hormones and the menopause transition.

Obstetrics and gynecology clinics of North America, 2011

6
Guideline

treatment of symptoms of the menopause: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2015

Related Questions

What is the recommended deworming medication and dosage for a 2-year-old child?
In a 43-year-old woman with perimenopausal symptoms and a small hemorrhagic simple ovarian cyst on ultrasound, are the new irregular periods normal for perimenopause?
What could a round bump on the inner labia (labia minora) of a 50‑year‑old Asian female represent, and what diagnostic tests should be performed?
What is the appropriate evaluation and management for a 5-year-old girl presenting with fever and a maculopapular rash involving the legs and the soles of her feet?
What is the evaluation and management for a 16‑month‑old with excessive drooling and inability to tolerate solid foods?
Are oxytocin (Pitocin) and penicillin G compatible for IV infusion?
Should emergency medical services (EMS) apply a pelvic binder (pelvic sheet) for a suspected hip fracture in an older adult patient?
Why would tesamorelin act differently in patients without HIV?
In a 53-year-old woman whose last menstrual period was 7 months ago, with hypertension treated with amlodipine, migraine with aura, bipolar disorder treated with olanzapine, BMI 28.1 kg/m², blood pressure 144/76 mm Hg, creatinine clearance 76 mL/min, and QTc 478 ms, what stage of the menopausal transition does she fall under according to the Stages of Reproductive Aging Workshop (STRAW) + 10 system?
What are the clinical signs of brainstem herniation?
For a 58-year-old postmenopausal woman concerned about venous thromboembolism, which hormone therapy was shown in the 2024 Swedish nationwide registry study to have no increased risk of VTE?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.